|
Vaccine Detail
S. pneumoniae 6PGD Protein Vaccine |
Vaccine Information |
- Vaccine Name: S. pneumoniae 6PGD Protein Vaccine
- Target Pathogen: Streptococcus pneumoniae
- Target Disease: Pneumonia
- Vaccine Ontology ID: VO_0004069
- Type: Subunit vaccine
- Status: Research
- Antigen: Recombinant 6-Phosphogluconate dehydrogenase (6PGD) (Daniely et al., 2006).
- Gnd
gene engineering:
- Type: Recombinant protein preparation
- Description:
- Detailed Gene Information: Click Here.
- Adjuvant: aluminum vaccine adjuvant
- Immunization Route: Intraperitoneal injection (i.p.)
|
Host Response |
Mouse Response
- Host Strain: BALB/c
- Vaccination Protocol: Six-week-old BALB/c female mice were immunized intraperitoneally with 25 µg of r6PGD and 75 µl of Inject Alum adjuvant on days 0 (primary immunization) and 21 (booster). Control mice were sham-immunized with adjuvant only (Daniely et al., 2006).
- Challenge Protocol: For respiratory challenge r6PGD immunized and control mice were anaesthetized with pentobarbital sodium (0·6 mg/kg) and inoculated intranasally with 1 × 10^8 S. pneumoniae strain WU2 (in 25 µl PBS). This inoculum's size was used as it was found to be the lowest that causes 100% mortality in our mouse model system within 96 h. Survival was monitored daily (Daniely et al., 2006).
- Efficacy: Immunization of mice with r6PGD protected 60% (P < 0.001) of mice for 5 days and 40% (P < 0.05) of the mice for 21 days following intranasal lethal challenge (Daniely et al., 2006).
|
References |
Daniely et al., 2006: Daniely D, Portnoi M, Shagan M, Porgador A, Givon-Lavi N, Ling E, Dagan R, Mizrachi Nebenzahl Y. Pneumococcal 6-phosphogluconate-dehydrogenase, a putative adhesin, induces protective immune response in mice. Clinical and experimental immunology. 2006; 144(2); 254-263. [PubMed: 16634799].
|
|